Blockchain-enabled quality by design system for clinical trials

基于区块链技术的临床试验质量源于设计体系

阅读:2

Abstract

INTRODUCTION: Blockchain technology offers a secure and distributed approach to data management that can strengthen the Quality by Design (QbD) framework in clinical trials. Integrating blockchain with QbD can enhance data integrity and promote participant safety. METHODS: A blockchain-enabled QbD architecture was developed to support systematic quality improvement in clinical trials. The interactions among its components and peers were described, and a prototype was implemented using Hyperledger Fabric. Data from a pilot clinical trial were used to evaluate its applicability. RESULTS: The prototype demonstrated that the proposed architecture efficiently facilitates immutable data exchange, enhances traceability among QbD activities, and supports secure collaboration between stakeholders. The system improved data consistency and enabled automated verification of trial processes. DISCUSSION: This study shows that blockchain technology can effectively enhance QbD implementation in clinical trials by improving data integration, transparency, and safety monitoring. The proposed architecture provides a feasible and scalable model for future clinical data management systems.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。